Results 151 to 160 of about 22,370 (168)

Incretin-based therapy: how do incretin mimetics and DPP-4 inhibitors fit into treatment algorithms for type 2 diabetic patients?

Best Practice & Research Clinical Endocrinology & Metabolism, 2009
Michael A. Nauck
exaly  

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

Diabetes, Obesity and Metabolism, 2012
Jens Juul Holst, Tina Vilsbøll, Filip K Knop   +2 more
exaly  

An Updated Review on Cancer Risk Associated with Incretin Mimetics and Enhancers

Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis and Ecotoxicology Reviews, 2015
Chin-Hsiao Tseng
exaly  

Protective Effects of Incretin Against Age-Related Diseases

Current Drug Delivery, 2019
Di Zhang
exaly  

The contribution of incretin hormones to the pathogenesis of type 2 diabetes

Best Practice & Research Clinical Endocrinology & Metabolism, 2009
Juris Meier
exaly  

Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives

Diabetes and Metabolism, 2013
Bo Ahrén
exaly  

Incretin drugs as modulators of atherosclerosis

Atherosclerosis, 2018
Enrique Gallego-Colon, Wojciech Wojakowski, Tomasz Francuz   +2 more
exaly  

Incretins

RCSB Protein Data Bank
openaire   +1 more source

The neuro-incretin concept

Regulatory Peptides, 2014
openaire   +2 more sources

Weighing in on the incretin revolution

Nature Metabolism
openaire   +2 more sources